Scoping available resources and tools used by investigators to set up and conduct malaria clinical trials in low and middle income countries within malaria endemic settings. Participate in the survey.
Whilst our understanding of drug resistant Plasmodium falciparum is quite well understood, the extent and nature of resistance in Plasmodium vivax parasites is for the most part unknown.
New guidelines help researchers undertaking systematic reviews and IPD meta-analyses to report their findings in a full and transparent manner.
CDC researcher discusses the benefits of attending the recent Ring-Stage Survival Assay training, an important tool for tracking antimalarial drug resistance, recently held in Cambodia by Institut Pasteur and WWARN.
The WWARN Gametocyte Carriage Study Group is assessing the risk factors associated with gametocyte carriage and clearance. Find out how you can join.
Our understanding of the extent and nature of resistance in P. vivax parasites is limited. WWARN’s new literature review summarises the global extent of reduced P. vivax susceptibility to the frontline antimalarial chloroquine.